Thanks to blog reader Craig for forwarding me a report on the EU's approval of a new
chewable tablet of Lipitor (the cholesterol lowering medication) geared for use in kids ages 10 and up.
And according to
a study published yesterday in the Journal Pediatrics, the market's probably bigger than once thought. The lead researcher of the study, one where over 20,000 kids' cholesterol levels were screened, was
quoted by the Wall Street Journal as stating that current pediatric cholesterol screening guidelines would have missed 36% of kids with, "
seriously high LDL".
Sigh.